Digest Réseau Comment ça marche
Réseau
/
Sociétés
AI
Non vérifié

AIM ImmunoTech Inc.

Ce que nous écrivons

BiotechnologieIndustrie pharmaceutiqueOncologieSantéVIH, SIDA et maladies auto-immunes

14 communiqués de presse

Voir tous les communiqués de presse
03/11/2025
Biotechnologie
Loi/Droit/Fiscalité
Médecine Santé Bien-être
AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue
Source
AIM ImmunoTech Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
04/09/2025
Biotechnologie
Médecine Santé Bien-être
AIM ImmunoTech Highlights Growing Body of Compelling Data of Ampligen for the Treatment of Pancreatic Cancer at Conference in Poland
Source
AIM ImmunoTech Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
28/02/2025
Biotechnologie
Annonces Économiques
AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza
Source
AIM ImmunoTech Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
17/12/2024
Oncologie
Santé
VIH, SIDA et maladies auto-immunes
Biotechnologie
Médecine - Divers
Industrie pharmaceutique
AIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual Meeting
Source
AIM ImmunoTech Inc.
Émetteur
Business Wire
1.00
0
16/12/2024
Science
Finance
Médecine - Divers
Associations/Professionnels
Biotechnologie
Santé
Industrie pharmaceutique
Oncologie
AIM ImmunoTech Reminds Shareholders to Vote “FOR” All Four Incumbent Board Members on the WHITE Universal Proxy Card
Source
AIM ImmunoTech Inc.
Émetteur
Business Wire
1.00
0
12/12/2024
Science
Finance
Biotechnologie
Médecine - Divers
Associations/Professionnels
Industrie pharmaceutique
Santé
Oncologie
AIM ImmunoTech Urges Shareholders to Vote on the WHITE Universal Proxy Card “FOR” All Four Incumbent Board Members
Source
AIM ImmunoTech Inc.
Émetteur
Business Wire
1.00
0
12/12/2024
Biotechnologie
Annonces Économiques
AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of Fatigue
Source
AIM ImmunoTech Inc.
Émetteur
GLOBENEWSWIRE
1.00
0
10/12/2024
Oncologie
Santé
VIH, SIDA et maladies auto-immunes
Santé Publique
Industrie pharmaceutique
Biotechnologie
Glass Lewis Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan, Thomas K. Equels and Dr. William M. Mitchell
Source
AIM ImmunoTech Inc.
Émetteur
Business Wire
1.00
0
05/12/2024
Science
Finance
Médecine - Divers
Associations/Professionnels
Biotechnologie
Industrie pharmaceutique
Santé
Oncologie
ISS Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan and Dr. William M. Mitchell
Source
AIM ImmunoTech Inc.
Émetteur
Business Wire
1.00
0
02/12/2024
Biotechnologie
VIH, SIDA et maladies auto-immunes
Santé
Industrie pharmaceutique
Oncologie
AIM ImmunoTech Issues Presentation Detailing Why Shareholders Should NOT Elect Activist Group’s Nominees to the Board
Source
AIM ImmunoTech Inc.
Émetteur
Business Wire
1.00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0